Double-blind Trial of Carbenoxolone Sodium Capsules in Duodenal Ulcer Therapy, Based on Endoscopic Diagnosis and Follow-up
- 16 September 1972
- Vol. 3 (5828), 661-664
- https://doi.org/10.1136/bmj.3.5828.661
Abstract
A high-dose double-blind trial of carbenoxolone sodium capsules (Duogastrone) in the treatment of duodenal ulceration was combined with endoscopic diagnosis and follow-up. Thirty-one ambulant patients with an endoscopically visible duodenal ulcer were allocated at random to a 12-week course of treatment with either carbenoxolone sodium 300 mg daily or a placebo. Symptomatic and endoscopic follow-up was performed at 2-4 weeks, 6-8 weeks, and 12-16 weeks. Carbenoxolone was shown to increase the rate of healing of duodenal ulcers in the early stages of treatment, but by 12 weeks there was no difference between the two groups. There was no significant difference in symptomatic improvement between the two groups at any stage of treatment. Side effects, especially hypokalaemia, were prominent in the patients treated with carbenoxolone. There was a poor relation between endoscopic and symptomatic improvement in patients on either form of treatment.Keywords
This publication has 14 references indexed in Scilit:
- PREMEDICATION FOR GASTROINTESTINAL ENDOSCOPYThe Lancet, 1972
- Duogastrone-induced hypokalaemic nephropathy and myopathy with myoglobinuriaPublished by Oxford University Press (OUP) ,1971
- Clinical study of Duogastrone in the treatment of duodenal ulcersGut, 1970
- Carbenoxolone in the treatment of duodenal ulcer.1967
- Carbenoxolone sodium in the treatment of gastric ulcer with special reference to side-effects.Gut, 1965
- Treatment of gastric ulceration with carbenoxolone sodium: clinical and radiological evaluation.BMJ, 1965
- Treatment of gastric ulcer with carbenoxolone sodium and oestrogensGut, 1965
- The pain of peptic ulceration.1955
- Mechanism of Pain in Peptic UlcerGastroenterology, 1953
- EXPERIMENTAL REFERRED PAIN FROM THE GASTRO-INTESTINAL TRACT. PART I. THE ESOPHAGUSJCI Insight, 1931